Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study
ConclusionsThe combination of gemcitabine and sirolimus is an active treatment in STS. Further investigation is warranted.ClinicalTrials.gov identifier: NCT01684449.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Chemotherapy | Hematology | Sarcomas | Soft Tissue Sarcoma | Spain Health | Study | Toxicology